Loading...

William Perry

Title(s)Professor In Residence, Psychiatry
SchoolHealth Sciences
Phone619-543-2827
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Perry received his Ph.D. from the California School of Professional Psychology, San Diego in 1989. He completed his Internship and post-doctoral Fellowship at UCSD. He is a Fellow of the National Academy of Neuropsychology (NAN) as well as the Society for Personality Assessment and he serves as the Executive Director of NAN. His primary position in the Department of Psychiatry is as Vice Chair for Program Development and Operations and as the
    Co-Director, Division of Clinical Psychiatry. He also serves as the Chief Supervising psychologist at UCSD-Medical Center and engages in neuropsychological assessments.

    Research Interests

    Dr. Perry’s primary research program focuses on inhibitory and information processing deficits in neuropsychiatric conditions. He is the recipient of several grants to study acutely, un-medicated psychiatric patients using psychophysiological measures in order to characterize their inhibitory functions. Additionally, he is interested in conducting longitudinal studies, relating information processing deficits to thought disorder, neuropsychological and clinical measures. Although a majority of his publications are on patients with bipolar illness and schizophrenia, he has funded grants to study people with substance use disorders as well as people with viral diseases such as HIV and Hepatitis C.

    Clinical Focus

    As an active clinical Director, Dr. Perry serves as an Attending and is engaged in Psychiatry Consultation-Liaison work. He oversees consultation programs that have been developed with the UCSD Anesthesia Pain Management Group, Transplantation services and the Burn Service. He also serves as the Chief Supervising Psychologist at UCSD-Medical Center and as a member of Neuropsychological Associates is involved in outpatient neuropsychological and psychodiagnostic assessment.

    More on Dr. Perry's clinical information

    Collapse Research 
    Collapse Research Activities and Funding
    Cannabis use and the endocannabinoid system in bipolar disorder
    NIH/NIDA R01DA043535May 1, 2018 - Feb 28, 2023
    Role: Principal Investigator
    Endocannabinoid system and inhibition in bipolar disorder
    NIH/NIMH R21MH097112Sep 1, 2012 - Jun 30, 2014
    Role: Principal Investigator
    INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER
    NIH/NIMH R01MH071916Aug 25, 2004 - Jun 30, 2010
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, Perry W, Eyler LT. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disord. 2019 Apr 26. PMID: 31025493.
      View in: PubMed
    2. Glen ET, Hostetter G, Ruff RM, Roebuck-Spencer TM, Denney RL, Perry W, Fazio RL, Garmoe WS, Bianchini KJ, Scott JG. Integrative Care Models in Neuropsychology: A National Academy of Neuropsychology Education Paper. Arch Clin Neuropsychol. 2019 Mar 01; 34(2):141-151. PMID: 30566626.
      View in: PubMed
    3. MacQueen DA, Minassian A, Kenton JA, Geyer MA, Perry W, Brigman JL, Young JW. Amphetamine improves mouse and human attention in the 5-choice continuous performance test. Neuropharmacology. 2018 08; 138:87-96. PMID: 29859849.
      View in: PubMed
    4. Kwiatkowski MA, Hellemann G, Sugar CA, Cope ZA, Minassian A, Perry W, Geyer MA, Young JW. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacol Biochem Behav. 2019 03; 178:42-50. PMID: 29289701.
      View in: PubMed
    5. Minassian A, Young JW, Geyer MA, Kelsoe JR, Perry W. The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania. Mol Neuropsychiatry. 2018 Feb; 3(3):151-156. PMID: 29594134.
      View in: PubMed
    6. MacQueen DA, Minassian A, Henry BL, Geyer MA, Young JW, Perry W. Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults. J Int Neuropsychol Soc. 2018 03; 24(3):283-293. PMID: 29032769.
      View in: PubMed
    7. Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology. 2017 Oct; 125:254-262. PMID: 28774856.
      View in: PubMed
    8. Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W. Everyday functional ability in HIV and methamphetamine dependence. Drug Alcohol Depend. 2017 06 01; 175:60-66. PMID: 28399475.
      View in: PubMed
    9. Brandel MG, Hirshman BR, McCutcheon BA, Tringale K, Carroll K, Richtand NM, Perry W, Chen CC, Carter BS. The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury. J Neurotrauma. 2017 03 01; 34(5):1005-1016. PMID: 27573722.
      View in: PubMed
    10. Perry W, McIlwain M, Kloezeman K, Henry BL, Minassian A. Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitor. Psychiatry Res. 2016 06 30; 240:278-283. PMID: 27138818.
      View in: PubMed
    11. Minassian A, Young JW, Cope ZA, Henry BL, Geyer MA, Perry W. Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology (Berl). 2016 Jan; 233(2):225-33. PMID: 26449721.
      View in: PubMed
    12. van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci Biobehav Rev. 2015 Nov; 58:4-18. PMID: 26297513.
      View in: PubMed
    13. Fuchs HF, Laughter V, Harnsberger CR, Broderick RC, Berducci M, DuCoin C, Langert J, Sandler BJ, Jacobsen GR, Perry W, Horgan S. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016 Jan; 30(1):251-8. PMID: 25847138.
      View in: PubMed
    14. Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. J Neurovirol. 2014 Dec; 20(6):561-70. PMID: 25326107.
      View in: PubMed
    15. van Enkhuizen J, Janowsky DS, Olivier B, Minassian A, Perry W, Young JW, Geyer MA. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. Eur J Pharmacol. 2015 Apr 15; 753:114-26. PMID: 25107282.
      View in: PubMed
    16. Morgan EE, Doyle KL, Minassian A, Henry BL, Perry W, Marcotte TD, Woods SP, Grant I. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Psychiatry Res. 2014 Dec 15; 220(1-2):527-34. PMID: 25081313.
      View in: PubMed
    17. van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, Geyer MA, Young JW. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology. 2014 Dec; 39(13):3112-22. PMID: 25005251.
      View in: PubMed
    18. Patt VM, Thomas ML, Minassian A, Geyer MA, Brown GG, Perry W. Disentangling working memory processes during spatial span assessment: a modeling analysis of preferred eye movement strategies. J Clin Exp Neuropsychol. 2014; 36(2):186-204. PMID: 24499103.
      View in: PubMed
    19. Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behav Pharmacol. 2014 Feb; 25(1):12-22. PMID: 24281153.
      View in: PubMed
    20. Henry BL, Minassian A, Patt VM, Hua J, Young JW, Geyer MA, Perry W. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. J Affect Disord. 2013 Sep 25; 150(3):948-54. PMID: 23759280.
      View in: PubMed
    21. Henry BL, Minassian A, Perry W. Everyday functional ability across different phases of bipolar disorder. Psychiatry Res. 2013 Dec 30; 210(3):850-6. PMID: 23643188.
      View in: PubMed
    22. Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W. Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc. 2013 Jul; 19(6):709-17. PMID: 23552464.
      View in: PubMed
    23. Tyler JA, Fox JP, Desai MM, Perry WB, Glasgow SC. Outcomes and costs associated with robotic colectomy in the minimally invasive era. Dis Colon Rectum. 2013 Apr; 56(4):458-66. PMID: 23478613.
      View in: PubMed
    24. Henry BL, Geyer MA, Buell M, Perry W, Young JW, Minassian A. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res. 2013 Jan 01; 236(1):210-220. PMID: 22960458.
      View in: PubMed
    25. Morgan EE, Woods SP, Rooney A, Perry W, Grant I, Letendre SL. Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. Clin Neuropsychol. 2012; 26(4):654-74. PMID: 22533778.
      View in: PubMed
    26. Sakamoto M, Perry W, Hilsabeck RC, Barakat F, Hassanein T. Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy. Clin Liver Dis. 2012 Feb; 16(1):27-42. PMID: 22321463.
      View in: PubMed
    27. Minassian A, Henry BL, Young JW, Masten V, Geyer MA, Perry W. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS One. 2011; 6(8):e24185. PMID: 21912623.
      View in: PubMed
    28. Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology (Berl). 2011 Jun; 215(4):697-707. PMID: 21279333.
      View in: PubMed
    29. Henry BL, Minassian A, Perry W. Effect of methamphetamine dependence on heart rate variability. Addict Biol. 2012 May; 17(3):648-58. PMID: 21182570.
      View in: PubMed
    30. Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry. 2010 Oct 01; 68(7):678-80. PMID: 20615494.
      View in: PubMed
    31. Posada C, Moore DJ, Woods SP, Vigil O, Ake C, Perry W, Hassanein TI, Letendre SL, Grant I. Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J Clin Exp Neuropsychol. 2010 Jul; 32(6):637-44. PMID: 20603743.
      View in: PubMed
    32. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res. 2010 Jun 30; 178(1):84-91. PMID: 20471103.
      View in: PubMed
    33. Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev. 2010 Jul; 34(8):1296-306. PMID: 20398694.
      View in: PubMed
    34. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav. 2010 Jul; 96(1):7-15. PMID: 20363246.
      View in: PubMed
    35. Carlson MD, Hilsabeck RC, Barakat F, Perry W. Role of Sleep Disturbance in Chronic Hepatitis C Infection. Curr Hepat Rep. 2010 Feb; 9(1):25-29. PMID: 20208985.
      View in: PubMed
    36. Henry BL, Minassian A, Perry W. Effect of methamphetamine dependence on everyday functional ability. Addict Behav. 2010 Jun; 35(6):593-8. PMID: 20167435.
      View in: PubMed
    37. Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W. The quantitative assessment of motor activity in mania and schizophrenia. J Affect Disord. 2010 Jan; 120(1-3):200-6. PMID: 19435640.
      View in: PubMed
    38. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl). 2010 Feb; 208(3):443-54. PMID: 20020109.
      View in: PubMed
    39. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry. 2009 Oct; 66(10):1072-80. PMID: 19805697.
      View in: PubMed
    40. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res. 2010 Feb; 44(3):168-76. PMID: 19700172.
      View in: PubMed
    41. Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS, Caldwell S, McGuire B, Nevens F, Fontana R. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol. 2009 Jun; 104(6):1392-400. PMID: 19455117.
      View in: PubMed
    42. Perry W. Beyond the numbers: expanding the boundaries of neuropsychology. Arch Clin Neuropsychol. 2009 Feb; 24(1):21-9. PMID: 19395354.
      View in: PubMed
    43. Feifel D, Minassian A, Perry W. Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res. 2009 Jan; 43(4):484-9. PMID: 18674783.
      View in: PubMed
    44. Vigil O, Posada C, Woods SP, Atkinson JH, Heaton RK, Perry W, Hassanein TI, Grant I, Letendre SL. Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol. 2008 Oct; 30(7):805-15. PMID: 18608687.
      View in: PubMed
    45. Dean KL, Viglione DJ, Perry W, Meyer GJ. A method to optimize the response range while maintaining Rorschach Comprehensive System validity. J Pers Assess. 2007 Oct; 89(2):149-61. PMID: 17764392.
      View in: PubMed
    46. Hassanein TI, Hilsabeck RC, Perry W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci. 2008 Feb; 53(2):529-38. PMID: 17710551.
      View in: PubMed
    47. Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci. 2008 Feb; 53(2):307-21. PMID: 17703362.
      View in: PubMed
    48. Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev. 2007; 31(6):882-96. PMID: 17706782.
      View in: PubMed
    49. Mooney S, Hasssanein TI, Hilsabeck RC, Ziegler EA, Carlson M, Maron LM, Perry W. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol. 2007 Feb; 22(2):175-86. PMID: 17280813.
      View in: PubMed
    50. Minassian A, Paulus M, Lincoln A, Perry W. Adults with autism show increased sensitivity to outcomes at low error rates during decision-making. J Autism Dev Disord. 2007 Aug; 37(7):1279-88. PMID: 17080271.
      View in: PubMed
    51. Minassian A, Feifel D, Perry W. The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res. 2007 Jan; 89(1-3):225-31. PMID: 17005374.
      View in: PubMed
    52. Perry W, Minassian A, Lopez B, Maron L, Lincoln A. Sensorimotor gating deficits in adults with autism. Biol Psychiatry. 2007 Feb 15; 61(4):482-6. PMID: 16460695.
      View in: PubMed
    53. Perry W, Carlson MD, Barakat F, Hilsabeck RC, Schiehser DM, Mathews C, Hassanein TI. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS. 2005 Oct; 19 Suppl 3:S79-84. PMID: 16251832.
      View in: PubMed
    54. Miller BP, Perry W, Moutier CY, Robinson SK, Feifel D. Rapid oral loading of extended release divalproex in patients with acute mania. Gen Hosp Psychiatry. 2005 May-Jun; 27(3):218-21. PMID: 15882770.
      View in: PubMed
    55. Minassian A, Granholm E, Verney S, Perry W. Visual scanning deficits in schizophrenia and their relationship to executive functioning impairment. Schizophr Res. 2005 Apr 01; 74(1):69-79. PMID: 15694756.
      View in: PubMed
    56. Perry W, Crean RD. A retrospective review of the neuropsychological test performance of physicians referred for medical infractions. Arch Clin Neuropsychol. 2005 Mar; 20(2):161-70. PMID: 15708726.
      View in: PubMed
    57. Hilsabeck RC, Hassanein TI, Perry W. Biopsychosocial predictors of fatigue in chronic hepatitis C. J Psychosom Res. 2005 Feb; 58(2):173-8. PMID: 15820845.
      View in: PubMed
    58. Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2005 Jan; 11(1):16-22. PMID: 15686604.
      View in: PubMed
    59. Minassian A, Paulus MP, Perry W. Increased sensitivity to error during decision-making in bipolar disorder patients with acute mania. J Affect Disord. 2004 Oct 15; 82(2):203-8. PMID: 15488248.
      View in: PubMed
    60. Feifel D, Farber RH, Clementz BA, Perry W, Anllo-Vento L. Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004 Sep 01; 56(5):333-9. PMID: 15336515.
      View in: PubMed
    61. Perry W, Minassian A, Feifel D. Prepulse inhibition in patients with non-psychotic major depressive disorder. J Affect Disord. 2004 Aug; 81(2):179-84. PMID: 15306146.
      View in: PubMed
    62. Maron LM, Carlson MD, Minassian A, Perry W. A process approach to verbal fluency in patients with schizophrenia. Schizophr Res. 2004 May 01; 68(1):105-6. PMID: 15037345.
      View in: PubMed
    63. Minassian A, Granholm E, Verney S, Perry W. Pupillary dilation to simple vs. complex tasks and its relationship to thought disturbance in schizophrenia patients. Int J Psychophysiol. 2004 Mar; 52(1):53-62. PMID: 15003372.
      View in: PubMed
    64. Anderson CM, Kerby JD, Perry WB, Sorrells DL. Pneumoretroperitoneum in two patients with Clostridium perfringens necrotizing pancreatitis. Am Surg. 2004 Mar; 70(3):268-71. PMID: 15055853.
      View in: PubMed
    65. Perry W. Let's call the whole thing off: a response to Dawes (2001). Psychol Assess. 2003 Dec; 15(4):582-5. PMID: 14692852.
      View in: PubMed
    66. Viglione DJ, Perry W, Meyer G. Refinements in the Rorschach Ego Impairment Index incorporating the human representational variable. J Pers Assess. 2003 Oct; 81(2):149-56. PMID: 12946921.
      View in: PubMed
    67. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2003 Sep; 9(6):847-54. PMID: 14632243.
      View in: PubMed
    68. Minassian A, Perry W, Carlson M, Pelham M, DeFilippis N. The category test perseveration, loss of set, and memory scales: three new scales and their relationship to executive functioning measures. Assessment. 2003 Sep; 10(3):213-21. PMID: 14503644.
      View in: PubMed
    69. Viglione DJ, Perry W, Jansak D, Meyer G, Exner JE. Modifying the Rorschach Human Experience Variable to create the Human Representational Variable. J Pers Assess. 2003 Aug; 81(1):64-73. PMID: 12842803.
      View in: PubMed
    70. Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess. 2003 Feb; 80(1):50-7. PMID: 12584067.
      View in: PubMed
    71. Robinson SK, McQuaid JR, Viirre ES, Betzig LL, Miller DL, Bailey KA, Harris JP, Perry W. Relationship of tinnitus questionnaires to depressive symptoms, quality of well-being, and internal focus. Int Tinnitus J. 2003; 9(2):97-103. PMID: 15106282.
      View in: PubMed
    72. Perry W, Feifel D, Minassian A, Bhattacharjie I, Braff DL. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am J Psychiatry. 2002 Aug; 159(8):1375-81. PMID: 12153831.
      View in: PubMed
    73. Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2002 Feb; 63(2):169. PMID: 11874225.
      View in: PubMed
    74. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002 Feb; 35(2):440-6. PMID: 11826421.
      View in: PubMed
    75. Auslander LA, Perry W, Jeste DV. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction. Schizophr Res. 2002 Jan 15; 53(3):199-207. PMID: 11738533.
      View in: PubMed
    76. Perry W, Minassian A, Feifel D, Braff DL. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001 Sep 15; 50(6):418-24. PMID: 11566158.
      View in: PubMed
    77. Perry W. Incremental validity of the Ego Impairment Index: a re-examination of Dawes (1999). Psychol Assess. 2001 Sep; 13(3):403-7. PMID: 11556278.
      View in: PubMed
    78. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15; 49(1-2):171-8. PMID: 11343875.
      View in: PubMed
    79. Perry W, Potterat EG, Braff DL. Self-monitoring enhances Wisconsin Card Sorting Test performance in patients with schizophrenia: performance is improved by simply asking patients to verbalize their sorting strategy. J Int Neuropsychol Soc. 2001 Mar; 7(3):344-52. PMID: 11311035.
      View in: PubMed
    80. Perry W, Heaton RK, Potterat E, Roebuck T, Minassian A, Braff DL. Working memory in schizophrenia: transient "online" storage versus executive functioning. Schizophr Bull. 2001; 27(1):157-76. PMID: 11215544.
      View in: PubMed
    81. Perry W, Light GA, Davis H, Braff DL. Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophr Res. 2000 Dec 15; 46(2-3):167-74. PMID: 11120428.
      View in: PubMed
    82. Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000 Dec; 61(12):909-11. PMID: 11206594.
      View in: PubMed
    83. Paulus MP, Perry W, Braff DL. The nonlinear, complex sequential organization of behavior in schizophrenic patients: neurocognitive strategies and clinical correlations. Biol Psychiatry. 1999 Sep 01; 46(5):662-70. PMID: 10472418.
      View in: PubMed
    84. Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl). 1999 Sep; 146(2):228-32. PMID: 10525760.
      View in: PubMed
    85. Cadenhead KS, Perry W, Shafer K, Braff DL. Cognitive functions in schizotypal personality disorder. Schizophr Res. 1999 May 25; 37(2):123-32. PMID: 10374648.
      View in: PubMed
    86. Granholm E, Perry W, Filoteo JV, Braff D. Hemispheric and attentional contributions to perceptual organization deficits on the global-local task in schizophrenia. Neuropsychology. 1999 Apr; 13(2):271-281. PMID: 10353376.
      View in: PubMed
    87. Perry W, Geyer MA, Braff DL. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry. 1999 Mar; 56(3):277-81. PMID: 10078506.
      View in: PubMed
    88. Perry W, Felger T, Braff D. The relationship between skin conductance hyporesponsivity and perseverations in schizophrenia patients. Biol Psychiatry. 1998 Sep 15; 44(6):459-65. PMID: 9777177.
      View in: PubMed
    89. Perry W, Braff DL. A multimethod approach to assessing perseverations in schizophrenia patients. Schizophr Res. 1998 Sep 07; 33(1-2):69-77. PMID: 9783346.
      View in: PubMed
    90. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL. Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res. 1997 Nov 07; 28(1):51-62. PMID: 9428064.
      View in: PubMed
    91. Cadenhead KS, Perry W, Braff DL. The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry. 1996 Nov 01; 40(9):853-8. PMID: 8896771.
      View in: PubMed
    92. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. Latent inhibition in schizophrenia. Schizophr Res. 1996 May; 20(1-2):91-103. PMID: 8794497.
      View in: PubMed
    93. Perry W, Moore D, Braff D. Gender differences on thought disturbance measures among schizophrenic patients. Am J Psychiatry. 1995 Sep; 152(9):1298-301. PMID: 7653684.
      View in: PubMed
    94. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. Drug screening in "normal" controls. Biol Psychiatry. 1995 Jul 15; 38(2):123-4. PMID: 7578645.
      View in: PubMed
    95. Perry W, Sprock J, Schaible D, McDougall A, Minassian A, Jenkins M, Braff D. Amphetamine on Rorschach measures in normal subjects. J Pers Assess. 1995 Jun; 64(3):456-65. PMID: 7760256.
      View in: PubMed
    96. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D, Kuck J, Zisook S, Jeste DV. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc. 1995 Jan; 1(1):88-99. PMID: 9375213.
      View in: PubMed
    97. Perry W, Braff DL. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 1994 Mar; 151(3):363-7. PMID: 8109644.
      View in: PubMed
    98. Perry W. Weiner's Psychodiagnosis in schizophrenia: a classic revisited. J Pers Assess. 1994 Feb; 62(1):180-6. PMID: 8138884.
      View in: PubMed
    99. Perry W, Viglione D, Braff D. The Ego Impairment Index and schizophrenia: a validation study. J Pers Assess. 1992 Aug; 59(1):165-75. PMID: 1512674.
      View in: PubMed
    100. Perry W, Viglione DJ. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants. J Pers Assess. 1991 Jun; 56(3):487-501. PMID: 1865307.
      View in: PubMed
    William's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (319) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (44) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑